Cover Image
市場調查報告書

神經血管支架:醫療設備的開發平台評估

Neurovascular Stents - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 358227
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
神經血管支架:醫療設備的開發平台評估 Neurovascular Stents - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年06月01日 內容資訊: 英文 70 Pages
簡介

本報告提供全球神經血管支架市場上主要的開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品功能·特性比較分析 (臨床實驗的各進展階段) ,還有主要企業簡介及代表性產品,彙整近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 神經血管支架概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 神經血管支架的企業:各臨床實驗階段的開發中產品
  • 神經血管支架:各臨床實驗階段的開發中產品

第5章 神經血管支架市場:企業·產品概要

  • Aneuclose LLC
  • Apeliotus Technologies
  • DePuy Synthes, Inc.
  • Gaudi Vascular, Inc.
  • InspireMD, Inc.
  • MicroVention, Inc.
  • NeuroSigma, Inc.
  • NSVascular, Inc.
  • Oxford Endovascular Limited
  • Palmaz Scientific, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology

第6章 神經血管支架市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Neurovascular Stents - Medical Devices Pipeline Assessment, 2017" provides an overview of Neurovascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Neurovascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Neurovascular Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Neurovascular Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Neurovascular Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Neurovascular Stents Overview 6

3 Products under Development 7

  • 3.1 Neurovascular Stents - Pipeline Products by Stage of Development 7
  • 3.2 Neurovascular Stents - Pipeline Products by Territory 8
  • 3.3 Neurovascular Stents - Pipeline Products by Regulatory Path 9
  • 3.4 Neurovascular Stents - Pipeline Products by Estimated Approval Date 10
  • 3.5 Neurovascular Stents - Ongoing Clinical Trials 11

4 Neurovascular Stents - Pipeline Products under Development by Companies 12

  • 4.1 Neurovascular Stents Companies - Pipeline Products by Stage of Development 12
  • 4.2 Neurovascular Stents - Pipeline Products by Stage of Development 13

5 Neurovascular Stents Companies and Product Overview 14

  • 5.1 Aneuclose LLC Company Overview 14
    • 5.1.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.2 Apeliotus Technologies Company Overview 15
    • 5.2.1 Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.3 Codman & Shurtleff Inc Company Overview 16
    • 5.3.1 Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.4 Cordis Corp Company Overview 18
    • 5.4.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.5 Gaudi Vascular, Inc. Company Overview 19
    • 5.5.1 Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.6 MicroPort Scientific Corp Company Overview 20
    • 5.6.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.7 MicroVention, Inc. Company Overview 21
    • 5.7.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.8 Neurosigma Inc Company Overview 25
    • 5.8.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.9 NSVascular, Inc. Company Overview 26
    • 5.9.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.10 Palmaz Scientific Inc Company Overview 27
    • 5.10.1 Palmaz Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 28
    • 5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.12 University of California Los Angeles Company Overview 29
    • 5.12.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 29

6 Neurovascular Stents- Recent Developments 30

  • 6.1 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 30
  • 6.2 Apr 23, 2017: Bard Announces First Quarter Results 31
  • 6.3 Mar 30, 2017: MPSC Announces 2016 Annual Results 31
  • 6.4 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 33
  • 6.5 Feb 16, 2017: InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 36
  • 6.6 Feb 14, 2017: MicroPort Receives CFDA Approval for APOLLO Intracranial Stent System in Large Sizes 37
  • 6.7 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 38
  • 6.8 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 38
  • 6.9 Jan 26, 2017: Bard Announces Fourth Quarter Results 40
  • 6.10 Dec 15, 2016: MicroPort NeuroTech Attends CINS 2016 40
  • 6.11 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 41
  • 6.12 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 44
  • 6.13 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 44
  • 6.14 Nov 14, 2016: InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2016 45
  • 6.15 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 47
  • 6.16 Oct 25, 2016: Bard Announces Third Quarter Results 49
  • 6.17 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 50
  • 6.18 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 50
  • 6.19 Sep 07, 2016: InspireMD Appoints Thomas Kester to Board of Directors 51
  • 6.20 Aug 30, 2016: MPSC Announces 2016 Interim Results 52
  • 6.21 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 53
  • 6.22 Aug 09, 2016: InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016 56
  • 6.23 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 58
  • 6.24 Jul 26, 2016: Bard Announces Second Quarter Results 60
  • 6.25 Jul 21, 2016: InspireMD Regains Compliance With NYSE MKT Listing Standards 61
  • 6.26 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 61
  • 6.27 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 61
  • 6.28 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 62
  • 6.29 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 62
  • 6.30 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 63

7 Appendix 67

  • 7.1 Methodology 67
  • 7.2 About GlobalData 70
  • 7.3 Contact Us 70
  • 7.4 Disclaimer 70

List of Tables

1.1 List of Tables

  • Table 1: Neurovascular Stents - Pipeline Products by Stage of Development 7
  • Table 2: Neurovascular Stents - Pipeline Products by Territory 8
  • Table 3: Neurovascular Stents - Pipeline Products by Regulatory Path 9
  • Table 4: Neurovascular S

List of Figures

1.2 List of Figures

  • Figure 1: Neurovascular Stents - Pipeline Products by Stage of Development 7
  • Figure 2: Neurovascular Stents - Pipeline Products by Territory 8
  • Figure 3: Neurovascular Stents - Pipeline Products by Regulatory Path 9
  • Figure 4: Neurovascular Stents - Pipeline Products by Estimated Approval Date 10
  • Figure 5: Neurovascular Stents - Ongoing Clinical Trials 11
Back to Top